Good evening :)
Switch to

Lupin Ltd

LUPIN
Health CarePharmaceuticals
LargecapWith a market cap of ₹33,455 cr, stock is ranked 84
Low RiskStock is 1.54x as volatile as Nifty
745.856.75 (+0.91%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Current price is more than the intrinsic value

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Stock has been generating better return on equity than bank FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Stock doesn't offer attractive dividend returns

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

Good time to consider, as stock is not in overbought zone

No Red Flags
ASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list, with high pledged promoter holding or high default probability should be handled with caution

Stock not in ASM/GSM lists, not a lot of promoter holding is pledged and default probability is low

Health CarePharmaceuticals
LargecapWith a market cap of ₹33,455 cr, stock is ranked 84
Low RiskStock is 1.54x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
55.33
PB RatioPB Ratio
2.43
Dividend YieldDiv. Yield
0.67%
Sector PESector PE
26.21
Sector PBSector PB
2.89
Sector Div YldSctr Div Yld
0.80%

Forecast & RatingsDetailed Forecast 

38%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lupin Limited is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.

Brands

Lupin

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201620172018201914.2517.4915.8016.712.262.550.250.60
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Press Release
Announced OnOct 9, 2019

Lupin Limited has informed the Exchange regarding a press release dated October 09, 2019, titled "Japan s PMDA issues GMP Certificate to Lupin s Unit II Mandideep facility ". | Download

Lupin Limited has informed the Exchange regarding a press release dated October 09, 2019, titled "Japan s PMDA issues GMP Certificate to Lupin s Unit II Mandideep facility ". | Download

News Verification
Announced OnOct 9, 2019

The Exchange has sought clarification from Lupin Limited with respect to recent news item captioned USFDA red flags Lupin for significant violations at MP unit. The response from the Company is attached. | Download

The Exchange has sought clarification from Lupin Limited with respect to recent news item captioned USFDA red flags Lupin for significant violations at MP unit. The response from the Company is attached. | Download

Cash Dividend
Ex. DateJul 30, 2018

Final • Div/Share: ₹ 5

See all events

Tickertape provides data, information & content for Indian stocks, ETFs & indices.

Data powered byPrices shown are delayed by 15 minutes© Tickertape 2019